MWM
HALO icon

Mascoma Wealth Management’s Halozyme HALO Stock Holding History

Mascoma Wealth Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$704 Buy
+9
New +$614 ﹤0.01% 533

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Mascoma Wealth Management's HALO Position: Q2 2026 in Review

Mascoma Wealth Management opened a new position in Halozyme (HALO) in Q2 2026: 9 shares worth $704. The stake represents ﹤0.01% of the portfolio and ranks #533 among its holdings.

668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Mascoma Wealth Management held 9 shares of Halozyme worth $704 as of Q2 2026.
  • Halozyme was a new Mascoma Wealth Management position in Q2 2026.
  • Halozyme made up ﹤0.01% of Mascoma Wealth Management's portfolio in Q2 2026, its #533 holding.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Mascoma Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.